Ivan Jacques Mikaelian

Title: Ivan Jacques Mikaelian: Innovator in Polypeptide Research

Introduction

Ivan Jacques Mikaelian is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with therapeutic applications. His work focuses on the modulation of cellular functions, which has implications for various medical treatments.

Latest Patents

Mikaelian holds 2 patents related to polypeptides that have modulatory effects on cells. His latest inventions involve peptides and polypeptides with the sequence SAVTFAVCAL or variants thereof. These compounds are capable of binding to Calcineurin and/or NS5A-TP2, and they are utilized in therapeutic applications. The inventions also encompass nucleic acid sequences and vectors that encode these peptides and polypeptides, as well as cells that incorporate them. Furthermore, his work explores the use of these peptides to induce phenotypic changes in mammalian cells, particularly in up-regulating calcineurin activity. Additionally, he has developed methods for the intracellular identification of substances that bind to calcineurin and modulate its physiological effects.

Career Highlights

Throughout his career, Mikaelian has been associated with prestigious institutions such as École Normale Supérieure de Lyon and the Centre National de la Recherche Scientifique. His research has significantly advanced the understanding of polypeptide functions and their potential therapeutic uses.

Collaborations

Mikaelian has collaborated with various professionals in his field, including his coworker Pierre Colas. Their joint efforts have contributed to the advancement of research in biotechnology and therapeutic applications.

Conclusion

Ivan Jacques Mikaelian is a prominent inventor whose work in polypeptides has the potential to impact therapeutic strategies significantly. His innovative research continues to pave the way for advancements in biotechnology and medicine.